Literature DB >> 14620503

pH-triggered release of macromolecules from spray-dried polymethacrylate microparticles.

Daniel S Kohane1, Daniel G Anderson, Christine Yu, Robert Langer.   

Abstract

PURPOSE: pH-triggered microparticles release their therapeutic payloads at acidic pH (e.g., in the phagosome), making intracellular drug delivery more efficient. Here we modify lipid-based microparticles that are safe and efficacious in nerve and brain and are potentially inhalable, making them pH-triggerable by incorporating an acid-soluble polymethacrylate, Eudragit E100 (E100).
METHODS: Microparticles were produced by spray-drying and characterized by electron microscopy, Coulter counting, density measurement, and release kinetics of fluorescently labeled proteins. In addition, biocompatibility and cellular uptake were observed in rats.
RESULTS: Microparticles were spheroids 3 to 5 microm in diameter with densities of 0.12 to 0.25 g/L. Microparticles with 20% (w/w) or more E100 demonstrated slow release of fluorescently labeled proteins at pH 7.4 but rapid release at pH 5. pH-triggerability was maintained for over 2 weeks in solution. Protein loadings of 0.2-20% (w/w) were pH-triggerable. Histologic examination of particles in rat connective tissue near nerve and muscle demonstrated biocompatibility aside from muscle edema in the cell layers adjacent to the particles and a localized inflammatory reaction with macrophages laden with microparticles.
CONCLUSIONS: Microparticles containing E100 were pH-triggerable for many days and were taken up by macrophages, suggesting that they may be useful for intracellular drug delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620503     DOI: 10.1023/a:1026162628965

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  Vaccines and mucosal immunisation.

Authors:  A W Cripps; J M Kyd; A R Foxwell
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

Review 2.  Recent advances in mucosal vaccine development.

Authors:  H Chen
Journal:  J Control Release       Date:  2000-07-03       Impact factor: 9.776

3.  New advances in microsphere-based single-dose vaccines.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-10-13       Impact factor: 15.470

4.  Effectiveness of muscimol-containing microparticles against pilocarpine-induced focal seizures.

Authors:  Daniel S Kohane; Gregory L Holmes; Ying Chau; David Zurakowski; Robert Langer; Byung Ho Cha
Journal:  Epilepsia       Date:  2002-12       Impact factor: 5.864

5.  Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility.

Authors:  Daniel S Kohane; Nikolaus Plesnila; Sunu S Thomas; Dean Le; Robert Langer; Michael A Moskowitz
Journal:  Brain Res       Date:  2002-08-16       Impact factor: 3.252

6.  Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres.

Authors:  Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Dev Technol       Date:  2002-11       Impact factor: 3.133

7.  Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses.

Authors:  M L Hedley; J Curley; R Urban
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

Review 8.  Synthetic DNA delivery systems.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

9.  Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres.

Authors:  J Castillo; J Curley; J Hotz; M Uezono; J Tigner; M Chasin; R Wilder; R Langer; C Berde
Journal:  Anesthesiology       Date:  1996-11       Impact factor: 7.892

10.  Neurologic evaluation of the rat during sciatic nerve block with lidocaine.

Authors:  J G Thalhammer; M Vladimirova; B Bershadsky; G R Strichartz
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

View more
  3 in total

Review 1.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

2.  An In Vitro Thrombolysis Study Using a Mixture of Fast-Acting and Slower Release Microspheres.

Authors:  Hoai X Nguyen; Edgar A O'Rear
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

3.  Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Authors:  Chirasak Kusonwiriyawong; Vimolmas Lipipun; Nontima Vardhanabhuti; Qiang Zhang; Garnpimol C Ritthidej
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.